Business · 27/12/2021Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Pathology Peer Review in Nonclinical Toxicology Studies
Summary
The Food and Drug Administration (FDA) has released a final guidance document addressing questions and answers regarding the management and conduct of pathology peer review in nonclinical toxicology studies, following the September 30, 2019, draft guidance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →